Mountain View Pharmaceuticals, Inc.
Records under this name other than the patents Mountain View Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Mountain View Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,783,965 | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates Formerly held Term ended Ended no later than Jan 25, 2024 · From the USPTO record | Term ended | Ended no later than Jan 25, 2024 | From the USPTO record |
| US 7,927,589 | Peg-Urate Oxidase Conjugates and Use Thereof Formerly held Term ended Ended no later than Dec 14, 2020 · Low confidence | Term ended | Ended no later than Dec 14, 2020 | Low confidence |
| US 7,927,852 | Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates Formerly held Term ended Ended no later than Sep 27, 2020 · Low confidence | Term ended | Ended no later than Sep 27, 2020 | Low confidence |
| US 8,618,267 | PEG-Urate Oxidase Conjugates and Use Thereof Formerly held Term ended Ended no later than May 30, 2020 · Low confidence | Term ended | Ended no later than May 30, 2020 | Low confidence |
| US 7,723,089 | Peg-Urate Oxidase Conjugates and Use Thereof Formerly held Term ended Ended no later than Apr 30, 2020 · Low confidence | Term ended | Ended no later than Apr 30, 2020 | Low confidence |
| US 6,316,185 | Quantitation of viruses by light scattering Term ended Term ended Sep 29, 2019 · From the USPTO record | Term ended | Term ended Sep 29, 2019 | From the USPTO record |
| US 6,544,770 | Quantitation of viruses by light scattering Term ended Term ended Sep 29, 2019 · From the USPTO record | Term ended | Term ended Sep 29, 2019 | From the USPTO record |
| US 9,125,880 | Polymer conjugates of interferon-beta with enhanced biological potency Lapsed on the fee record Ended Sep 8, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2019 | From the USPTO record |
| US 6,576,235 | PEG-urate oxidase conjugates and use thereof Formerly held Term ended Term ended Aug 6, 2019 · From the USPTO record | Term ended | Term ended Aug 6, 2019 | From the USPTO record |
| US 8,067,553 | Peg-Urate Oxidase Conjugates and Use Thereof Formerly held Term ended Term ended Aug 6, 2019 · Medium confidence | Term ended | Term ended Aug 6, 2019 | Medium confidence |